Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Preliminary effect and feasibility of physiotherapy with strength training and protein-rich nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients with hip fracture: protocol for a blinded randomized controlled pilot trial (HIP-SAP1 trial)

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nonunion - consensus from the 4th annual meeting of the Danish Orthopaedic Trauma Society

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An exercise program for people with severe peripheral neuropathy and diabetic foot ulcers - a case series on feasibility and safety

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Challenges in optimising recovery after emergency laparotomy

    Research output: Contribution to journalReviewResearchpeer-review

  4. Reliability of the Copenhagen Achilles length measure (CALM) on patients with an Achilles tendon rupture

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: A 2014 Cochrane review evaluating the effect of anabolic steroids after hip fracture concluded that the quality of the studies was insufficient to draw conclusions on the effects and recommended further high-quality trials in the field. Therefore, the aim of this pilot trial is to determine the preliminary effect and feasibility of a 12-week multimodal intervention consisting of physiotherapy (with strength training), protein-rich nutritional supplement and anabolic steroid on knee-extension muscle strength and function 14 weeks after hip fracture surgery.

METHODS: We plan to conduct a randomized, placebo-controlled pilot trial with 48 patients operated for acute hip fracture. The patients are randomized (1:1) to either (1) physiotherapy with protein-rich nutritional supplement plus anabolic steroid or (2) physiotherapy with protein-rich nutritional supplement plus placebo. Outcome assessments will be carried out blinded at baseline (3-10 days after surgery) and at 14 weeks after entering the trial. Primary outcome is the change from baseline to follow-up in maximal isometric knee-extension muscle strength in the fractured limb. Secondary outcomes are physical performance test, patient-reported outcomes, and measures of body composition.

DISCUSSION: If the trial is found feasible and the results show an indication of anabolic steroid being a relevant addition to further enhance the recovery of muscle strength and function in an enhanced recovery after surgery program, this trial will constitute the basis of a larger confirmatory trial.

TRIAL REGISTRATION: ClinicalTrials.gov, NCT03545347. Preregistered on 4 June 2018.

Original languageEnglish
Article number763
JournalTrials
Volume20
ISSN1745-6215
DOIs
Publication statusPublished - 23 Dec 2019

ID: 58720952